Drugdiscovery >> Drugs >> News
6267
Views
Remicade Copies Approved in Europe - drugdiscovery.com
Remicade Copies Approved in Europe - drugdiscovery.com


J&J’s Remicade, a drug for arthritis, will have cheaper versions made and sold by two other companies in Europe by 2014.
Read More >>


Tags: Remicade, Arthritis, Celltrion, Hospira - July 20, 2013
Related Articles
6038
Views
First biosimilar mAb therapy approved in Europe First biosimilar mAb therapy approved in Europe
Hospira’s Inflectra, monoclonal antibody (mAb) therapy, a biosimilar to Remicade (infliximab), has been approved by the European Commission (EC) for the treatment of inflammatory conditions includin Read More >>

Tags: Hospira, Inflectra, infliximab, Remicade, biosimilar, monoclonal antibody, inflamatory conditions, treatment, Europe

6966
Views
Boehringer Ingelheim’s lung cancer drug afatinib (Giotrif ) approved in Europe Boehringer Ingelheim’s lung cancer drug afatinib (Giotrif ) approved in Europe
The European Commission has granted marketing authorization for afatinib, used as monotherapy for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC Read More >>

Tags: Giotrif, afatinib, locally advanced, metastatic, non-small cell lung cancer, NSCLC, EGFR mutation, EU, Europe

10284
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

11880
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

8072
Views
Takeda's schizophrenia drug lurasidone approved in Swiss Takeda's schizophrenia drug lurasidone approved in Swiss
This is the first approval in Europe for lurasidone, which is already marketed as Latuda for schizophrenia and bipolar depression in the US and Canada. Read More >>

Tags: lurasidone, latuda, drug, schizophrenia, bipoloar disorder, Swiss, approval, Europe

2416
Views
Lojuxta authorised in Europe Lojuxta authorised in Europe
The European Commission has authorised Lojuxta, by Aegerion Pharmaceuticals, for the treatment of patients with life threatening, rare inherited disease called homozygous familial hypercholesterolaemi Read More >>

Tags: Lojuxta, Aegerion Pharmaceuticals, homozygous familial hypercholesterolaemia

4196
Views
Europe-wide cancer research collabortion is announced Europe-wide cancer research collabortion is announced
European institutions announced a collaboration for cancer research. CRT and Nuevolution says, this going to help to delvelop a trustable cure for as wide range of cancer types. Read More >>

Tags: CRT, Nuevolution, cancer, drug

3946
Views
Three New European Marketing Authorizations for Takeda Three New European Marketing Authorizations for Takeda
The European Commission has granted Marketing Authorization (MA) for Vipidia (alogliptin) for the treatment of type 2 diabetes patients who are uncontrolled on existing therapies and for the fixed-dos Read More >>

Tags: Takeda, EMA, EC, Europe, marketing authorisation, type 2 diabetes, Vipidia, alogliptin, Vipdoment, Incresync

14560
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

4014
Views
Orexigen seeks approval for obesity drug Contrave in EU Orexigen seeks approval for obesity drug Contrave in EU
If approved after an eagerly-anticipated interim analysis of a cardiovascular outcomes trial called the Light study, the drug might be launched in EU in early 2015. Contrave (naltrexone/bupropion) i Read More >>

Tags: Orexigen, EU, Europe, Contrave, drug, obesity, depression, cravings

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013